Correlation Between Oncolytics Biotech and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Terns Pharmaceuticals, you can compare the effects of market volatilities on Oncolytics Biotech and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Terns Pharmaceuticals.
Diversification Opportunities for Oncolytics Biotech and Terns Pharmaceuticals
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Oncolytics and Terns is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and Terns Pharmaceuticals
Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the Terns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.21 times less risky than Terns Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Terns Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 721.00 in Terns Pharmaceuticals on August 26, 2024 and sell it today you would lose (142.00) from holding Terns Pharmaceuticals or give up 19.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Oncolytics Biotech |
| Terns Pharmaceuticals |
Oncolytics Biotech and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and Terns Pharmaceuticals
The main advantage of trading using opposite Oncolytics Biotech and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Oncolytics Biotech vs. Eliem Therapeutics | Oncolytics Biotech vs. HCW Biologics | Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Akari Therapeutics PLC | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |